Jandeleit-Dahm, S
Galindo is supported in part by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institute of Health (NIH) under award numbers P30DK111024, 1K23DK123384, 1R03DK138255, and 1U2CDK137135
According to the Texas Board of Pharmacy, a May 2022 inspection of the facility led to a mandate that the pharmacy immediately cease production of compounded sterile preparations due to pharmacist training failures, insufficient cleaning, and insufficient recordkeeping
None of these replace a prescription, and if youre managing a condition like type 2 diabetes or obesity, you need to see a healthcare provider before making major dietary changes
The fact that SAEs in the retatrutide groups have not exceeded those in the placebo groups is reassuring
As a family and obesity medicine physician, my focus is not only on treating and preventing metabolic conditions but also ensuring that the well-being of both mother and baby is prioritized